Vimta Labs consolidated net profit rises 140.92% in the September 2024 quarter
08 - Nov - 2024 12:00 AM | 73 days ago
Net profit of Vimta Labs rose 140.92% to Rs 15.25 crore in the quarter ended September 2024 as against Rs 6.33 crore during the previous quarter ended September 2023. Sales rose 29.30% to Rs 84.74 crore in the quarter ended September 2024 as against Rs 65.54 crore during the previous quarter ended September 2023.
Vimta Labs completes sale of its diagnostic and pathological services business
11 - Oct - 2024 12:00 AM | 101 days ago
Vimta Labs has completed the sale and transfer of its diagnostic and pathological services business as a going concern to Thyrocare Technologies on 11 October 2024.
Vimta Labs completes sale of its diagnostic and pathological services business
11 - Oct - 2024 12:00 AM | 101 days ago
Vimta Labs has completed the sale and transfer of its diagnostic and pathological services business as a going concern to Thyrocare Technologies on 11 October 2024.
Vimta Labs consolidated net profit rises 0.66% in the June 2024 quarter
17 - Jul - 2024 12:00 AM | 187 days ago
Net profit of Vimta Labs rose 0.66% to Rs 12.28 crore in the quarter ended June 2024 as against Rs 12.20 crore during the previous quarter ended June 2023. Sales declined 2.07% to Rs 81.76 crore in the quarter ended June 2024 as against Rs 83.49 crore during the previous quarter ended June 2023.
Vimta Labs consolidated net profit rises 140.92% in the September 2024 quarter
08 - Nov - 2024 12:00 AM | 73 days ago
Net profit of Vimta Labs rose 140.92% to Rs 15.25 crore in the quarter ended September 2024 as against Rs 6.33 crore during the previous quarter ended September 2023. Sales rose 29.30% to Rs 84.74 crore in the quarter ended September 2024 as against Rs 65.54 crore during the previous quarter ended September 2023.
Vimta Labs completes sale of its diagnostic and pathological services business
11 - Oct - 2024 12:00 AM | 101 days ago
Vimta Labs has completed the sale and transfer of its diagnostic and pathological services business as a going concern to Thyrocare Technologies on 11 October 2024.
Vimta Labs consolidated net profit rises 0.66% in the June 2024 quarter
17 - Jul - 2024 12:00 AM | 187 days ago
Net profit of Vimta Labs rose 0.66% to Rs 12.28 crore in the quarter ended June 2024 as against Rs 12.20 crore during the previous quarter ended June 2023. Sales declined 2.07% to Rs 81.76 crore in the quarter ended June 2024 as against Rs 83.49 crore during the previous quarter ended June 2023.
Vimta Labs consolidated net profit rises 140.92% in the September 2024 quarter
08 - Nov - 2024 12:00 AM | 73 days ago
Net profit of Vimta Labs rose 140.92% to Rs 15.25 crore in the quarter ended September 2024 as against Rs 6.33 crore during the previous quarter ended September 2023. Sales rose 29.30% to Rs 84.74 crore in the quarter ended September 2024 as against Rs 65.54 crore during the previous quarter ended September 2023.
Vimta Labs completes sale of its diagnostic and pathological services business
11 - Oct - 2024 12:00 AM | 101 days ago
Vimta Labs has completed the sale and transfer of its diagnostic and pathological services business as a going concern to Thyrocare Technologies on 11 October 2024.
Vimta Labs completes sale of its diagnostic and pathological services business
11 - Oct - 2024 12:00 AM | 101 days ago
Vimta Labs has completed the sale and transfer of its diagnostic and pathological services business as a going concern to Thyrocare Technologies on 11 October 2024.
Vimta Labs consolidated net profit rises 0.66% in the June 2024 quarter
17 - Jul - 2024 12:00 AM | 187 days ago
Net profit of Vimta Labs rose 0.66% to Rs 12.28 crore in the quarter ended June 2024 as against Rs 12.20 crore during the previous quarter ended June 2023. Sales declined 2.07% to Rs 81.76 crore in the quarter ended June 2024 as against Rs 83.49 crore during the previous quarter ended June 2023.